Compared to the healthy individuals, expression levels of BRG1 and DDIT4 were remarkably augmented in the livers of patients diagnosed with nonalcoholic steatohepatitis (NASH). The gene discussed is SMARCA4; the disease is metabolic dysfunction-associated steatohepatitis.